The corneal implants market has seen considerable growth due to a variety of factors.
•The market for corneal implants has witnessed substantial growth in the past few years. The market, which was worth $1.34 billion in 2024, is expected to rise to $1.43 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.4%.
The previous growth trend can be linked to innovative surgical techniques, early innovation in biomaterials, the advent of keratoplasty, increasing knowledge about eye disorders, and the substantial contributions from pioneering surgeons.
The corneal implants market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for robust expansion in the corneal implants market in the upcoming years. The market is projected to reach $1.9 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.4%.
The expected growth in this specific forecast period is due to various factors such as the advent of personalized medicine, enhanced accessibility and awareness, innovative developments in biomaterials, an increase in refractive surgeries, and a burgeoning aged population. Major trends during this forecast period encompass the emergence of minimally invasive techniques, administrative backing and approvals, heightened awareness and accessibility, breakthroughs in biomaterials, and a surge in refractive surgery.
The rise in incidents of corneal ailments is expected to push forward the expansion of the corneal implant market. Medical issues impacting the cornea - the transparent, dome-shaped front surface of the eye - are known as corneal disorders, and they trigger visual deterioration and discomfort. The escalating incidence of corneal disorders has led to a spike in demand for corneal implants. These implants offer a variety of solutions for dealing with corneal anomalies, fortifying corneal integrity, alleviating symptoms and enhancing eyesight. For example, as per the Center for Disease Control (CDC), a federal agency based in the United States, in December 2022, around 20.5 million people over the age of 40 are suffering from cataracts (a type of corneal disorder), accounting for roughly 17.2% of the population in this age bracket. Moreover, this number is forecasted to surpass 30 million by 2028. Consequently, the escalating incidences of corneal disorders are propelling the growth of the corneal implant market.
The corneal implants market covered in this report is segmented –
1) By Implant Type: Artificial Corneal Implant, Human Corneal Implant
2) By Procedure Type: Endothelial Keratoplasty, Penetrating Keratoplasty, Other Procedure Types
3) By Application: Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, Other Applications
4) By End-User: Hospitals, Ophthalmic Center, Other End-Users
Subsegments:
1) By Artificial Corneal Implant: Keratoprosthesis, Artificial Cornea
2) By Human Corneal Implant: Donor Cornea, Preserved Cornea
Major businesses in the corneal implants market are prioritizing the development of novel corneal contouring solutions to improve vision correction procedures and manage a variety of corneal disorders. This innovative corneal contouring refers to the modern surgical procedures and devices that are created to restructure the cornea for improved vision and treatment of refractive errors or corneal diseases. To illustrate, in June 2024, CorneaGen, a medical devices company based in the US with a goal to eradicate corneal blindness, introduced Corneal Tissue Addition for Keratoplasty (CTAK), a pioneering and highly potent solution for corneal contouring specific to keratoconic eyes. CTAK uses a unique method of supplementing the existing cornea with donor corneal tissue instead of completely replacing it. This approach is designed to restore the original shape of the cornea, thus improving optical clarity.
Major companies operating in the corneal implants market include:
• Florida Lions Eye Bank Inc.
• Alcon Inc.
• Aurolab Aravind Eye Care System
• CorneaGen
• AJL Ophthalmic SA
• DIOPTEX Co. Ltd.
• KeraMed Inc.
• Alabama Eye Bank Inc.
• CorNeat Vision Ltd.
• MediPhacos
• EyeYon Medical Ltd.
• Linkocare Life Sciences AB
• Price Vision Group
• Cornea Biosciences LLC
• Massachusetts Eye and Ear Infirmary
• Carl Zeiss Meditec AG
• Precise Bio Inc.
• Bausch & Lomb Incorporated
• Johnson & Johnson Vision
• Abbott Medical Optics Inc.
• STAAR Surgical Company
• ZEISS Group
• Hoya Corporation
• Rayner Intraocular Lenses Limited
• HumanOptics AG
• Morcher GmbH
• Lenstec Inc.
• Ocular Systems Inc.
• Moria SA
• DORC International BV
• Coroneo Pty Ltd
• FCI Ophthalmics Inc.
North America was the largest region in the cornea implants market in 2024.Asia Pacific is expected to be the fastest-growing region in the global cornea implants market during the forecast period. The regions covered in the corneal implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa